Effect of Short-Time BelAgeTM Prescription on Pregnancy and Risk Preeclampsia

##plugins.themes.bootstrap3.article.sidebar##

PDF
Published Mar 13, 2022
DOI https://doi.org/10.20428/yjms.v15i1.1879

##plugins.themes.bootstrap3.article.main##

Alejandra Lisbeth Rodríguez Zamora
Mónica Pretelini Sáenz” Maternal-Perinatal Hospital (HMPMPS)
José Anaya Herrera
Mónica Pretelini Sáenz” Maternal-Perinatal Hospital (HMPMPS)
Fanny Palma Navarrete
Mónica Pretelini Sáenz” Maternal-Perinatal Hospital (HMPMPS)
Hugo Mendieta Zerón
Mónica Pretelini Sáenz” Maternal-Perinatal Hospital (HMPMPS). Faculty of Medicine, Autonomous University of the State of Mexico (UAEMéx)

Abstract

Introduction: The aim was to determine if one month taking BelAgeTM in the second trimester of pregnancy could reduce the risk of preeclampsia.


Methods: From April 2019 to July 2020, a non-blinded, prospective, randomized, study was performed inviting women in the second trimester of pregnancy to take 3 g of BelAgeTM once daily for one month. The control group received only the nutritional assessment. Relative risk (RR) to develop preeclampsia with 95% confidence interval (CI) was calculated using the Social Science Statistics online software, considering a significant statistical value a P-value < 0.05.


Results: 144 patients from the BelAgeTM group (mean age 23.6 ± 9.7), and 99 from the control group (mean age 22.1 ± 8.6) were included, finding differences basal systolic blood pressure (P = 0.03), final diastolic blood pressure (P = 0.002) and final mean blood pressure (P = 0.001). Preeclampsia was developed by 18 patients in the BelAgeTM group versus ten patients in the control group, RR 1.2 (95% CI, 0.60–2.57, P = 0.57).


Conclusion: A short-time BelAgeTM prescription in the second trimester of pregnancy was enough to reduce the DBP, but did not reduce the risk of developing preeclampsia.


Keywords: BelAgeTM diastolic blood pressure, preeclampsia, relative risk.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

Keywords

BelAge®, diastolic blood pressure, preeclampsia, relative risk.

Issue
Vol. 15 No. 1 (2021)
Section
Original Article
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

YJMS publishes Open Access articles under the Creative Commons Attribution (CC BY) license. If author(s) submit their manuscript for consideration by YJMS, they agree to have the CC BY license applied to their work, which means that it may be reused in any form provided that the author(s) and the journal are properly cited. Under this license, author(s) also preserve the right of reusing the content of their manuscript provided that they cite the YJMS.

How to Cite
Rodríguez Zamora, A. L., Herrera, J. A. ., Palma Navarrete, F. ., & Mendieta Zerón, H. . (2022). Effect of Short-Time BelAgeTM Prescription on Pregnancy and Risk Preeclampsia. Yemeni Journal for Medical Sciences, 15(1). https://doi.org/10.20428/yjms.v15i1.1879